given as a subcutaneous injection. Dupixent is a biologic and belongs to a drug class called interleukin-4 (IL-4) receptor blockers. The medication is not available in a biosimilar version.
For an in-depth look and details about the drug’s uses, see this Dupixent overview article. Dupixent pen and Dupixent syringe are used to give Dupixent doses by subcutaneous injection.
Hosted on MSN1mon
He paid $38,398 for a single shot of a very old cancer drugDrugs like Dupixent for eczema fall into this category ... If you’re about to get an injection, infusion, or procedure done in a hospital system, ask ahead of time for an estimate of what ...
Global healthcare company Sanofi and Regeneron Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injection to patients suffering from ...
Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...
These drugs inhibit interleukin (IL)-5, while Dupixent inhibits IL-4 and IL-13, but can be considered a rival because it is also an injection. Patients may opt to take the others because of their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback